Advertisement

Uncategorized

With decreased reimbursements, declining case volume and physicians heading toward hospital employment, there may not seem to be a lot of reason for cheer in the ambulatory surgery center industry this holiday season. But don’t give up hope just yet…

The U.S. Food and Drug Administration has revoked its approval of the drug Avastin for breast cancer on the grounds that it has not been shown to be safe and effective for that use, according to an FDA news release.

Advertisement

Prominent anesthesiology journals are more likely to publish positive results than negative ones, according to a study conducted by researchers at Chicago’s Northwestern University and reported in Anesthesiology News. Read the full report in Becker’s ASC Review on anesthesiology research.

Advertisement